Literature DB >> 2105487

Activation of the pp60c-src protein kinase is an early event in colonic carcinogenesis.

C A Cartwright1, A I Meisler, W Eckhart.   

Abstract

Colonic neoplasia provides an opportunity to study tumor progression because most carcinomas arise from adenomas (polyps), which, in turn, arise from normal epithelia. The malignant potential of adenomas varies with size, histology, and degree of dysplasia. Polyps that are less than 2 cm with villous architecture and severe dysplasia are most likely to contain carcinoma. Previous studies demonstrated that the in vitro protein-tyrosine kinase activity of pp60c-src from colon carcinomas is significantly higher than that from adjacent normal mucosa. Here we report that the protein kinase activity of pp60c-src is also elevated in colonic polyps. Activity is highest in malignant polyps and in greater than 2-cm benign polyps that contain villous structure and severe dysplasia. Thus, pp60c-src activation occurs in benign polyps that are at greatest risk for developing cancer. These data suggest that activation of the protooncogene product pp60c-src may be an important event in the genesis of human colon carcinoma.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2105487      PMCID: PMC53304          DOI: 10.1073/pnas.87.2.558

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Analysis of pp60c-src protein kinase activity in human tumor cell lines and tissues.

Authors:  N Rosen; J B Bolen; A M Schwartz; P Cohen; V DeSeau; M A Israel
Journal:  J Biol Chem       Date:  1986-10-15       Impact factor: 5.157

2.  Cell transformation by pp60c-src mutated in the carboxy-terminal regulatory domain.

Authors:  C A Cartwright; W Eckhart; S Simon; P L Kaplan
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

3.  A tail of two src's: mutatis mutandis.

Authors:  T Hunter
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

4.  Prevalence of ras gene mutations in human colorectal cancers.

Authors:  J L Bos; E R Fearon; S R Hamilton; M Verlaan-de Vries; J H van Boom; A J van der Eb; B Vogelstein
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

5.  Consistent deficiencies of chromosome 18 and of the short arm of chromosome 17 in eleven cases of human large bowel cancer: a possible recessive determinism.

Authors:  M Muleris; R J Salmon; B Zafrani; J Girodet; B Dutrillaux
Journal:  Ann Genet       Date:  1985

6.  Deregulation of c-myc gene expression in human colon carcinoma is not accompanied by amplification or rearrangement of the gene.

Authors:  M D Erisman; P G Rothberg; R E Diehl; C C Morse; J M Spandorfer; S M Astrin
Journal:  Mol Cell Biol       Date:  1985-08       Impact factor: 4.272

7.  Aberrant expression of an amplified c-myb oncogene in two cell lines from a colon carcinoma.

Authors:  K Alitalo; R Winqvist; C C Lin; A de la Chapelle; M Schwab; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

8.  Phosphorylation sites in enolase and lactate dehydrogenase utilized by tyrosine protein kinases in vivo and in vitro.

Authors:  J A Cooper; F S Esch; S S Taylor; T Hunter
Journal:  J Biol Chem       Date:  1984-06-25       Impact factor: 5.157

9.  Activation of pp60c-src protein kinase activity in human colon carcinoma.

Authors:  J B Bolen; A Veillette; A M Schwartz; V DeSeau; N Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

10.  Detection of the c-myc oncogene product in colonic polyps and carcinomas.

Authors:  J Stewart; G Evan; J Watson; K Sikora
Journal:  Br J Cancer       Date:  1986-01       Impact factor: 7.640

View more
  62 in total

1.  Autophagic targeting of Src promotes cancer cell survival following reduced FAK signalling.

Authors:  Emma Sandilands; Bryan Serrels; David G McEwan; Jennifer P Morton; Juan Pablo Macagno; Kenneth McLeod; Craig Stevens; Valerie G Brunton; Wallace Y Langdon; Marcos Vidal; Owen J Sansom; Ivan Dikic; Simon Wilkinson; Margaret C Frame
Journal:  Nat Cell Biol       Date:  2011-12-04       Impact factor: 28.824

2.  Src tyrosine kinase phosphorylation of nuclear receptor HNF4α correlates with isoform-specific loss of HNF4α in human colon cancer.

Authors:  Karthikeyani Chellappa; Lucy Jankova; Jake M Schnabl; Songqin Pan; Yann Brelivet; Caroline L-S Fung; Charles Chan; Owen F Dent; Stephen J Clarke; Graham R Robertson; Frances M Sladek
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

3.  Raf-1 kinase, epidermal growth factor receptors, and mutant Ras proteins in colonic carcinomas.

Authors:  S Eggstein; G Manthey; T Hirsch; F Baas; B U Specht; E H Farthmann
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

4.  Expression of fatty acyl-CoA binding proteins in colon cells: response to butyrate and transformation.

Authors:  R E Gossett; F Schroeder; J M Gunn; A B Kier
Journal:  Lipids       Date:  1997-06       Impact factor: 1.880

5.  Design and synthesis of phosphotyrosine peptidomimetic prodrugs.

Authors:  Hugo Garrido-Hernandez; Kyung D Moon; Robert L Geahlen; Richard F Borch
Journal:  J Med Chem       Date:  2006-06-01       Impact factor: 7.446

6.  Pervanadate stabilizes desmosomes.

Authors:  David R Garrod; Christal Fisher; Angela Smith; Zhuxiang Nie
Journal:  Cell Adh Migr       Date:  2008-07-03       Impact factor: 3.405

7.  RACK1, a receptor for activated C kinase and a homolog of the beta subunit of G proteins, inhibits activity of src tyrosine kinases and growth of NIH 3T3 cells.

Authors:  B Y Chang; K B Conroy; E M Machleder; C A Cartwright
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

8.  Bombesin enhances TGF-beta growth inhibitory effect through apoptosis induction in intestinal epithelial cells.

Authors:  Xianghua Liu; Junmei Zhao; Fazhi Li; Yan-shi Guo; Mark R Hellmich; Courtney M Townsend; Yanna Cao; Tien C Ko
Journal:  Regul Pept       Date:  2009-07-23

9.  A new method for isolating tyrosine kinase substrates used to identify fish, an SH3 and PX domain-containing protein, and Src substrate.

Authors:  P Lock; C L Abram; T Gibson; S A Courtneidge
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

Review 10.  Protein kinases in human breast cancer.

Authors:  W G Cance; E T Liu
Journal:  Breast Cancer Res Treat       Date:  1995-07       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.